Stock Market

HCL Tech bags multi-year deal from Biotech firm Genmab

HCL Technologies has signed a multi-year contract with biotechnology firm Genmab to support its IT infrastructure operations globally, it said, without disclosing the deal value.

from Markets-Economic Times https://ift.tt/3k6isan

No comments

Powered by Blogger.